Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Per Sørensen MD, DMSc

Per Soelberg Sørensen MD, DMSc

Professor and Senior Consultant, Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Per Soelberg Sorensen is Professor of Neurology at the University of Copenhagen and senior consultant at Department of Neurology, Rigshospitalet, Copenhagen. In 1994 he founded the Danish Multiple Sclerosis Center, Rigshospitalet, with a large multidisciplinary multiple sclerosis clinic caring for more than 2200 patients, offering highly specialized therapies, and the Multiple Sclerosis Research Unit and Neuroimmunology Laboratory at Rigshospitalet.

He has authored 439 scientific publications indexed in PubMed. Google Scholar: h-index: 81, no. of citations: 34,005; i10-index: 306; Web-of-Science: h-index: 71; no. of citations: 26,356; average citations pr. item: 32.06.

Professor Sorensen has held several honorary offices including: President of the Danish Neurological Society (1991–1994) and the Danish Society for Research in Multiple Sclerosis (1995–2001); Executive Member (1996–2000 and 2010-2016), Treasurer (2011-2014), and Secretary General (2014-2016)m of the European Committee for Treatment and Research in Multiple Sclerosis; Executive Board member of the European Academy of Neurology 2014-2018; Member of the Clinical Scientific Committee of the Progressive MS Alliance (PMSA) 2012-2020, and Member of the International Advisory Committee on Clinical Trials in MS 2010-2020.

Professor Sorensen was Founding Editor-in-chief of the European Journal of Neurology from 1994 to 2003.

Currently Professor Sorensen’s appointments include: Executive Board member of the European Charcot Foundation for Research in Multiple Sclerosis; Member of the Medical Advisory Board of the International Federation of Multiple Sclerosis Societies (IFMSS).

Professor Sorensen has been awarded the International Monrad-Krohn Prize in 2014 and the MSIF Charcot Award in 2017; he is Honorary Member European Committee for Treatment and Research in Multiple Sclerosis, Honorary Member of the Danish Neurological Society, and Membre d’honneur de la Société Française de Neurologie.


P. S. Sørensen has received personal compensation for serving on scientific advisory boards, steering committees, independent data monitoring committees or have received speaker honoraria for Biogen, Merck, Novartis, TEVA, Celgene, and Roche.

Recent Contributions to PracticeUpdate:

  1. De-Escalating Rituximab Dose Stabilizes Multiple Sclerosis